Novozymes and Monsanto complete closing of The BioAg Alliance

The BioAg Alliance will discover, develop and sell microbial solutions that enable farmers worldwide to increase crop yields with less input

Copenhagen, Denmark, and St. Louis, USA – Novozymes (NASDAQ OMX: NZYM B) and Monsanto Company (NYSE: MON) today announce they have completed the closing of the The BioAg Alliance, as announced on December 10, 2013. The announcement follows the satisfaction of relevant closing conditions and the receipt of required regulatory approvals. Both companies will now focus on implementing the long-term strategic alliance.

The BioAg Alliance is unique in the industry, bringing together Novozymes’ commercial BioAg operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities. The result will be a comprehensive research, development and commercial collaboration for sustainable microbial products to help farmers globally meet the challenge of producing more with less – for the benefit of agriculture, consumers, the environment and society at large.

Contact information

Bryan Hurley – Investors & analysts
(+1 314-694-8148)
Sara Miller – Media
(+1 314-694-5824)
Investor Relations:
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+45 3077 0236
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339